Anteilseigner
Matrix Capital Management Co. LP (19,67 %) Eventide Asset Management LLC (16,29 %) Fidelity Management & Research Co. LLC (13,59 %) The Vanguard Group, Inc. (7,31 %) SSgA Funds Management, Inc. (6,22 %) BlackRock Fund Advisors (6,03 %) Citadel Advisors LLC (5,09 %) T. Rowe Price Associates, Inc. (Investment Management) (4,01 %) Capital Research & Management Co. (International Investors) (3,97 %) T. Rowe Price Investment Management, Inc. (3,30 %) Federated Global Investment Management Corp. (3,04 %) Decheng Capital LLC (2,96 %) Woodline Partners LP (1,98 %) Geode Capital Management LLC (1,77 %) Sofinnova Investments, Inc. (1,71 %) PRIMECAP Management Co. (1,44 %) Tybourne Capital Management (HK) Ltd. (1,35 %) Kevin Duane Bunker (1,20 %) Dimensional Fund Advisors LP (1,02 %)
Kontakt
Zentalis Pharmaceuticals Inc.